PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset
Presentation Product Chemical substance Chapter Items dispensed
Co Q10 10mg capsules
091102000BBAPBB
Proprietary compound preparation BNF 0911020 Other enzyme preparations 0911020 Nutrition and Blood No data available
Co-amilofruse 1.25mg/10mg/5ml oral liquid
0202040B0AAAMAM
Co-amilofruse Co-amilofruse (Amiloride hydrochloride/frusemide) Cardiovascular System No data available
Co-amilofruse 10mg/80mg/5ml oral liquid
0202040B0AAAIAI
Co-amilofruse Co-amilofruse (Amiloride hydrochloride/frusemide) Cardiovascular System No data available
Co-amilofruse 2.5mg/20mg/5ml oral liquid
0202040B0AAAJAJ
Co-amilofruse Co-amilofruse (Amiloride hydrochloride/frusemide) Cardiovascular System No data available
Co-amilozide 5mg/50mg/5ml oral solution
0202040C0AAACAC
Co-amilozide Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) Cardiovascular System No data available
Co-amoxiclav 250mg/125mg dispersible tablets sugar free
0501013K0AAABAB
Co-amoxiclav Co-amoxiclav (Amoxicillin/clavulanic acid) Infections No data available
Co-beneldopa 12.5mg/50mg/5ml oral suspension
0409010K0AAANAN
Co-beneldopa Co-beneldopa (Benserazide/levodopa) Central Nervous System No data available
Co-beneldopa 25mg/100mg/5ml oral liquid
0409010K0AAAHAH
Co-beneldopa Co-beneldopa (Benserazide/levodopa) Central Nervous System No data available
Co-beneldopa 25mg/6.25mg/5ml oral suspension
0409010K0AAAPAP
Co-beneldopa Co-beneldopa (Benserazide/levodopa) Central Nervous System No data available
Co-Betaloc SA tablets
0204000W0BBABAB
Co-Betaloc Metoprolol tartrate with diuretic Cardiovascular System No data available
Co-Betaloc tablets
0204000W0BBAAAA
Co-Betaloc Metoprolol tartrate with diuretic Cardiovascular System No data available
Co-careldopa 10mg/100mg/5ml oral suspension
0409010N0AAAJAJ
Co-careldopa Co-careldopa (Carbidopa/levodopa) Central Nervous System No data available
Co-careldopa 10mg/40mg/5ml oral suspension
0409010N0AAAYAY
Co-careldopa Co-careldopa (Carbidopa/levodopa) Central Nervous System No data available
Co-careldopa 2.5mg/10mg/5ml oral suspension
0409010N0AAAQAQ
Co-careldopa Co-careldopa (Carbidopa/levodopa) Central Nervous System No data available
Co-careldopa 25mg/250mg/5ml oral suspension
0409010N0AAAIAI
Co-careldopa Co-careldopa (Carbidopa/levodopa) Central Nervous System No data available
Co-careldopa 5mg/50mg/5ml oral suspension
0409010N0AAAXAX
Co-careldopa Co-careldopa (Carbidopa/levodopa) Central Nervous System No data available
Co-careldopa 625microgram/2.5mg/5ml oral suspension
0409010N0AAATAT
Co-careldopa Co-careldopa (Carbidopa/levodopa) Central Nervous System No data available
Co-codamol 30mg/500mg effervescent powder sachets sugar free
0407010F0AAAQAQ
Co-codamol Co-codamol (Codeine phosphate/paracetamol) Central Nervous System No data available
Co-codamol 60mg/1000mg effervescent pdr sachets sugar free
0407010F0AAARAR
Co-codamol Co-codamol (Codeine phosphate/paracetamol) Central Nervous System No data available
Co-codamol 60mg/1000mg tablets
0407010F0AAAYAY
Co-codamol Co-codamol (Codeine phosphate/paracetamol) Central Nervous System No data available
Co-codamol 8mg/500mg/5ml oral liquid
0407010F0AAASAS
Co-codamol Co-codamol (Codeine phosphate/paracetamol) Central Nervous System No data available
Co-codaprin 8mg/400mg dispersible tablets
0407010M0AAABAB
Co-codaprin Co-codaprin (Codeine phosphate/aspirin) Central Nervous System No data available
Co-codaprin 8mg/400mg tablets
0407010M0AAAAAA
Co-codaprin Co-codaprin (Codeine phosphate/aspirin) Central Nervous System No data available
Co-danthramer 25mg/200mg capsules
0106020B0AAACAC
Co-danthramer Co-danthramer (Dantron/poloxamer 188) Gastro-Intestinal System No data available
Co-danthramer 25mg/200mg/5ml oral suspension
0106020B0AAAHAH
Co-danthramer Co-danthramer (Dantron/poloxamer 188) Gastro-Intestinal System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.